Reveal Pharmaceuticals
Natural Resources · Rare Earth Metals
Facts
as of Nov 18, 2026Reveal Pharmaceuticals is developing RVP-001, a gadolinium-free, manganese-based general purpose MRI contrast agent in Phase 2 clinical studies with FDA Fast Track designation.
- Headquarters
- Cambridge, United States
- Employees
- 51-200estimated range
- Website
- revealpharma.com
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
What the registers and the postings say about this employer.
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Footprint
Hiring in 1 city in 1 country.
1Cities
1Countries
| Site | Type | Open roles | Hires most for | Engineering |
|---|---|---|---|---|
| Cambridge United States | Headquarters | 0 |
Source: office addresses in postings and company registers
Financials
10 public grants on record, $15.7M in total.
$15.7MPublic grants10 public grants
Money by yearUSD, rounds and grants
Sources: funding announcements, grant and company registers
Milestones
Sep 1, 2023
Won a grant $1.9M · CORDIS
Jun 5, 2023
Won a grant $4.1M · CORDIS
Each milestone is dated by its source: registers, filings, the press
